Upstream Bio, Inc. - COMMON STOCK (UPB)

CUSIP: 91678A107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+6,455,037
Put/Call ratio
50%
SEC-reported price per share
$27.15
Number of holders
133
Value change
+$178,186,919
Number of buys
83
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,984,855

Security key

91678A107

Report period

Q4 2025

Institutions

133

Top holders

10

Ownership snapshot

Top reported holders of UPB - Upstream Bio, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
FMR LLC
Comparable rows
2/15
Latest evidence
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 4.1% 13 rows are not safely comparable across share classes. 13D/G row: HBM Healthcare Investments (Cayman) Ltd. Showing 1-6 of 15 holder rows.

Quick read

HBM Healthcare Investments (Cayman) Ltd. leads the comparable SEC ownership view at 4.1%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HBM Healthcare Investments (Cayman) Ltd.'s linked filing trail.
Comparable ownership Top 2
HBM Healthcare Investments (Cayma... 4.1%
TCG Crossover GP I, LLC 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
13D/G
4.1%
Reported 13D/G · 30 Sep 2025
$41,290,257
2,195,111 shares
-$9,780,217 30 Sep 2025
TCG Crossover GP I, LLC
13D/G
3.9%
Reported 13D/G · 30 Sep 2025
$39,822,919
2,117,103 shares
-$12,878,523 30 Sep 2025
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$107,096,409
5,693,589 shares
— 30 Sep 2025
AI Upstream LLC
3/4/5
10%+ Owner
—
denominator unverified
—
5,494,410 shares
— 15 Oct 2024
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
3/4/5
10%+ Owner
—
denominator unverified
—
894,733 shares
— 15 Oct 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$152,105,434
8,086,413 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
133
Shares
51,176,304
Rows available
133
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
94
Q4 2025 holders
133
Holder diff
39
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .